Drug intelligence / Profile preview

Niaotong Kakenaiqi Tablets

Development stage: Unknown
Lead developer: Xinjiang Yinduolan Pharmaceutical
Administration: Oral

Overview

Niaotong Kakenaiqi Tablets (尿通卡克乃其片) is a traditional Uyghur herbal medicine developed and manufactured by Xinjiang Yinduolan Uighur Medicine Co., Ltd. It is formulated as an oral tablet based on traditional Uyghur medicine theory. The drug is indicated for the treatment of urinary tract or urogenital conditions, as suggested by its name 'Niaotong' (urinary passage). While the specific molecular mechanism of action has not been defined in modern pharmacological terms, it is a multi-herb formulation. Toxicity studies in rats have demonstrated a high safety profile, with no significant toxic effects observed at doses up to 50 times the proposed clinical dose.

Brand names: Niaotong Kakenaiqi Tablets
Other names: 尿通卡克乃其片Niaotong Kakenaiqi Pian

Beyond the preview

Go deeper on Niaotong Kakenaiqi Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niaotong Kakenaiqi Tablets.

Explore the full profile